TCL Archive Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis. October 24, 2008
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive “Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says November 4, 1994
TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013
